Skip to content
Search

Latest Stories

GPhC appoints Gisela Abbam as its new chair

General Pharmaceutical Council (GPhC) has appointed Gisela Abbam as its new chair.

Appointment of Abbam, who will assume office on March 14, 2022, was made by the Privy Council after a robust selection process which was scrutinised by the Professional Standards Authority.


She will take over from the current chair, Nigel Clarke, who has been in position since 2014 and has completed the statutory maximum eight years in office.

Commenting on her appointment, Abbam said: "I am delighted and honoured to be appointed as the new chair of the General Pharmaceutical Council and I look forward to leading the Council to achieve its vision of safe and effective pharmacy care at the heart of healthier communities.

“Covid-19 highlighted the increased role of pharmacists, pharmacy technicians and pharmacies in providing clinical services. Effective standards and regulation can help pharmacy to provide more support to patients and the public at large. I look forward to working with Council, the Executive team and staff and collaborating with other organisations to improve the health of people using pharmacy services."

Welcoming Abbam to the Council, Clarke, said: “Gisela is joining the GPhC at an exciting time of major changes in both pharmacy and health regulation. I am sure her vast experience in healthcare will help the GPhC drive forward the aims set out in our Vision 2030, and bring a real focus on the difference we want to make for patients and the public.”

Previously, Abbam was chair of the British Science Association (BSA). During her tenure, she led the BSA’s Council and championed the BSA mission and vision, driving forward an agenda on equality, diversity, and inclusion in STEM (Science, Technology, Engineering and Maths).

She has worked in collaboration with governments, the World Health Organisation, the United Nations, and other multilateral organisations to improve health outcomes for people across the world.

She is also the senior director government affairs for EMEAI at PerkinElmer, a global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalised drugs, monitor the safety and quality of food.

Besides, she serves on a number of advisory committees and sits on the Board of Everywoman Ltd., an organisation dedicated to advancing women in business.

Many in the industry congratulated the Council on the new appointment.

Welcoming the new GPhC chair, Mark Lyonette, chief executive of National Pharmacy Association wrote on twitter, “looking forward to meeting @gmabbam once she starts.

Mark tweet

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less